GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
Clinical trial NCT07581405 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07581405
- Sponsor
- University of Illinois at Chicago
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-09-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.